60 kDa heat shock protein, mitochondrial |
P10809 |
Stress response |
Post-treatment (NaOCl) |
Aldehyde oxidase |
Q06278 |
Inflammatory response, reactive oxygen species metabolic process |
Abscess |
Complement C3 |
P01024 |
Complement activation |
Abscess |
Cystatin-S |
CYTS_HUMAN |
Protease inhibitor |
Initial (asymptomatic); post-treatment (CHX/NaOCl) |
Cystatin-SA |
CYTT_HUMAN |
Protease inhibitor |
Initial (asymptomatic); post-treatment (NaOCl) |
Cystatin-SN |
CYTN_HUMAN/P01037
|
Protease inhibitor |
Abscess; initial (asymptomatic); post-treatment (CHX/NaOCl) |
Cytotoxic T-lymphocyte protein 4 |
P16410 |
Adaptive immunity |
Abscess |
G2/mitotic-specific cyclin-B2 |
O95067 |
T cell homeostasis |
Abscess |
Haptoglobin |
HPT_HUMAN (+5)/P00738
|
Acute-phase response |
Abscess; initial (asymptomatic) |
Histone H2B type F-S |
P57053 |
Defense response to bacterial infection |
Abscess; initial (asymptomatic) |
Ig alpha-1 chain C region |
P01876 |
Adaptive immunity, antigen binding |
Initial (asymptomatic) |
Ig gamma-3 chain C region |
IGHG3_HUMAN/P01860
|
Adaptive immunity, Fc-gamma receptor signaling pathway involved in phagocytosis |
Abscess; initial (asymptomatic); post-treatment (NaOCl) |
Ig kappa chain C region |
IGKC_HUMAN (+7)/P01834
|
Adaptive immunity, Fc-gamma receptor signaling pathway involved in phagocytosis |
Abscess; initial (asymptomatic); post-treatment (CHX/NaOCl) |
Ig lambda chain C regions |
P01842 |
Adaptive immunity, Fc-gamma receptor signaling pathway involved in phagocytosis |
Abscess; initial (asymptomatic) |
Interleukin enhancer-binding factor 2 |
Q12905 |
Immune response |
Post-treatment (NaOCl) |
Lymphoid-specific helicase |
HELLS_HUMAN |
Lymphocyte proliferation |
Abscess |
Lymphokine-activated killer T-cell-originated protein kinase |
Q96KB5 |
Lymphocyte cell activation |
Abscess |
Myeloperoxidase |
P05164 |
Respiratory burst involved in defense response |
Abscess |
Neutrophil cytosol factor 4 |
Q15080 |
Antigen processing and presentation of exogenous peptide antigen via MHC class I |
Abscess |
Neutrophil defensin 1 |
DEF1_HUMAN (+1)/P59665
|
Defense response to bacterial infection, chemotaxis |
Abscess; initial (asymptomatic); post-treatment (NaOCl) |
Neutrophil defensin 3 |
P59666 |
Defense response to bacterial infection |
Abscess; initial (asymptomatic); post-treatment (NaOCl) |
Polymeric immunoglobulin receptor |
PIGR_HUMAN |
IgA and IgM receptor |
Initial (asymptomatic); post-treatment (CHX/NaOCl) |
Prolactin-inducible protein |
PIP_HUMAN |
Expressed in pathological conditions |
Initial (asymptomatic); post-treatment (NaOCl) |
Protein S100-A9 |
P06702 |
Chronic inflammatory response, defense response to bacterial infection, chemokine production, response to lipopolysaccharide |
Initial (asymptomatic) |